Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 13.79
(0.95%)
CNY 13.79
(0.95%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.35 Billion CNY | -11.78% |
| 2022 | 3.46 Billion CNY | 27.27% |
| 2021 | 2.72 Billion CNY | 32.53% |
| 2020 | 2.05 Billion CNY | 25.89% |
| 2019 | 1.63 Billion CNY | 12.9% |
| 2018 | 1.44 Billion CNY | 29.67% |
| 2017 | 1.11 Billion CNY | 41.33% |
| 2016 | 789.39 Million CNY | 83.48% |
| 2015 | 430.24 Million CNY | 26.84% |
| 2014 | 339.19 Million CNY | 26.56% |
| 2013 | 268 Million CNY | 45.64% |
| 2012 | 184.01 Million CNY | 46.58% |
| 2011 | 125.54 Million CNY | 42.6% |
| 2010 | 88.04 Million CNY | 25.06% |
| 2009 | 70.39 Million CNY | 66.63% |
| 2008 | 42.24 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 746.46 Million CNY | 25.18% |
| 2024 Q1 | 596.33 Million CNY | -35.61% |
| 2024 Q3 | 541.91 Million CNY | -7.96% |
| 2023 FY | 3.05 Billion CNY | -11.78% |
| 2023 Q3 | 620.64 Million CNY | -8.65% |
| 2023 Q2 | 679.38 Million CNY | 24.0% |
| 2023 Q4 | 926.12 Million CNY | 49.22% |
| 2023 Q1 | 547.91 Million CNY | -38.77% |
| 2022 Q3 | 830.91 Million CNY | -10.42% |
| 2022 Q1 | 814.6 Million CNY | -20.45% |
| 2022 FY | 3.46 Billion CNY | 27.27% |
| 2022 Q4 | 894.81 Million CNY | 7.69% |
| 2022 Q2 | 927.59 Million CNY | 13.87% |
| 2021 FY | 2.72 Billion CNY | 32.53% |
| 2021 Q1 | 542.48 Million CNY | -24.14% |
| 2021 Q4 | 1.02 Billion CNY | 53.66% |
| 2021 Q3 | 666.37 Million CNY | 35.43% |
| 2021 Q2 | 492.03 Million CNY | -9.3% |
| 2020 Q2 | 481.31 Million CNY | 44.44% |
| 2020 Q4 | 715.07 Million CNY | 35.84% |
| 2020 FY | 2.05 Billion CNY | 25.89% |
| 2020 Q3 | 526.39 Million CNY | 9.37% |
| 2020 Q1 | 333.21 Million CNY | -21.72% |
| 2019 Q4 | 425.65 Million CNY | -5.3% |
| 2019 FY | 1.63 Billion CNY | 12.9% |
| 2019 Q1 | 357.88 Million CNY | -22.26% |
| 2019 Q2 | 400.15 Million CNY | 11.81% |
| 2019 Q3 | 449.48 Million CNY | 12.33% |
| 2018 Q2 | 308.05 Million CNY | 24.75% |
| 2018 Q1 | 246.93 Million CNY | -28.64% |
| 2018 Q3 | 431.28 Million CNY | 40.0% |
| 2018 Q4 | 460.33 Million CNY | 6.74% |
| 2018 FY | 1.44 Billion CNY | 29.67% |
| 2017 Q1 | 223.89 Million CNY | -15.13% |
| 2017 Q3 | 298.51 Million CNY | 20.78% |
| 2017 Q4 | 346.04 Million CNY | 15.92% |
| 2017 FY | 1.11 Billion CNY | 41.33% |
| 2017 Q2 | 247.16 Million CNY | 10.39% |
| 2016 FY | 789.39 Million CNY | 83.48% |
| 2016 Q4 | 263.81 Million CNY | 32.59% |
| 2016 Q3 | 198.97 Million CNY | 4.42% |
| 2016 Q2 | 190.54 Million CNY | 40.06% |
| 2016 Q1 | 136.04 Million CNY | 16.61% |
| 2015 Q3 | 115.81 Million CNY | 4.54% |
| 2015 Q4 | 116.66 Million CNY | 0.74% |
| 2015 Q1 | 86.98 Million CNY | -5.5% |
| 2015 FY | 430.24 Million CNY | 26.84% |
| 2015 Q2 | 110.78 Million CNY | 27.36% |
| 2014 Q3 | 93.37 Million CNY | 8.77% |
| 2014 FY | 339.19 Million CNY | 26.56% |
| 2014 Q1 | 67.91 Million CNY | -4.41% |
| 2014 Q2 | 85.85 Million CNY | 26.41% |
| 2014 Q4 | 92.04 Million CNY | -1.42% |
| 2013 Q4 | 71.04 Million CNY | -7.15% |
| 2013 FY | 268 Million CNY | 45.64% |
| 2013 Q1 | 50.17 Million CNY | -8.27% |
| 2013 Q2 | 70.26 Million CNY | 40.06% |
| 2013 Q3 | 76.51 Million CNY | 8.89% |
| 2012 Q2 | 45.89 Million CNY | 44.28% |
| 2012 Q4 | 54.69 Million CNY | 5.96% |
| 2012 Q3 | 51.61 Million CNY | 12.48% |
| 2012 Q1 | 31.8 Million CNY | -20.98% |
| 2012 FY | 184.01 Million CNY | 46.58% |
| 2011 Q4 | 40.25 Million CNY | 24.23% |
| 2011 FY | 125.54 Million CNY | 42.6% |
| 2011 Q2 | 32.09 Million CNY | 54.35% |
| 2011 Q1 | 20.79 Million CNY | -18.48% |
| 2011 Q3 | 32.4 Million CNY | 0.97% |
| 2010 Q1 | 14.81 Million CNY | 0.0% |
| 2010 Q4 | 25.5 Million CNY | 4.63% |
| 2010 Q3 | 24.37 Million CNY | 4.4% |
| 2010 Q2 | 23.34 Million CNY | 57.6% |
| 2010 FY | 88.04 Million CNY | 25.06% |
| 2009 FY | 70.39 Million CNY | 66.63% |
| 2008 FY | 42.24 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 358.41 Million CNY | -835.435% |
| Dirui Industrial Co.,Ltd. | 387.16 Million CNY | -765.977% |
| Beijing Strong Biotechnologies, Inc. | 702.74 Million CNY | -377.095% |
| Medicalsystem Biotechnology Co., Ltd. | 562.06 Million CNY | -496.507% |
| Maccura Biotechnology Co.Ltd | 1.18 Billion CNY | -184.031% |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.17 Billion CNY | -185.247% |
| Guangdong Hybribio Biotech Co.,Ltd. | 631.43 Million CNY | -430.972% |
| BGI Genomics Co., Ltd. | 1.93 Billion CNY | -72.889% |
| Amoy Diagnostics Co., Ltd. | 574.96 Million CNY | -483.122% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 479.96 Million CNY | -598.535% |